PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCM19
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $151,934
Award facts
- Contract value 100% obligated
- $151,933.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $151,933.50 from the Defense Logistics Agency's Medical Supply Chain on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract employs firm fixed-price pricing and was competitively awarded without a set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, will perform all work at this location. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen's federal contract portfolio demonstrates significant capability in pharmaceutical distribution, encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc., holds an even larger IDC with the Defense Logistics Agency valued at up to $999.99 million through December 31, 2031, further establishing the organization's role as a critical vendor for federal military and veteran healthcare systems. The DLA Medical Supply Chain contracts reflect the government's reliance on established pharmaceutical prime vendors to ensure consistent access to essential medical products for service members and military treatment facilities globally.
Quick answers
Who was awarded contract SPE2D826FCM19?
SPE2D826FCM19 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 15, 2026.
How much is contract SPE2D826FCM19 worth?
The government has obligated $151,934 on SPE2D826FCM19.
Is contract SPE2D826FCM19 an order under another contract?
Yes. SPE2D826FCM19 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FCM19 competed?
The extent of competition for SPE2D826FCM19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award